Corneal disease in patients with VKC and AKC ranges from Tranta's dots, superficial punctuate keratitis, shield ulcer, corneal plaque, corneal neovascularization, lipid infiltration, viral ...

GSK has been enjoying regulatory momentum in recent months as it works to bring its antibody-drug conjugate (ADC) Blenrep ...

KALA Bio completes enrollment in CHASE trial, advancing KPI-012 for treating persistent corneal epithelial defects. Topline ...

This article will discuss the underlying pathological mechanisms and the clinical features of corneal involvement in allergic eye disease and outline current and new options for treatment.